Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul-Sep;11(3):132-135.
doi: 10.4103/JCAS.JCAS_69_18.

Mondor's Disease after Aesthetic Breast Surgery: A Case Series and Literature Review

Affiliations

Mondor's Disease after Aesthetic Breast Surgery: A Case Series and Literature Review

Alberto Goldman et al. J Cutan Aesthet Surg. 2018 Jul-Sep.

Abstract

Background: Mondor's disease of the subcutaneous veins of the breast is an uncommon disorder. The etiology of Mondor's disease remains unclear. Usually, it is a self-limited disease. This condition has been associated with trauma, surgical biopsies, breast surgery (including silicone breast implant), physical activity, and a manifestation of breast cancer.

Materials and methods: This is a retrospective analysis of 652 female patients who underwent aesthetic breast surgery in the last 10 years.

Results: We found three cases of Mondor's disease after plastic surgery of the breast (0.46%) and performed an analysis of the clinical aspects and therapeutic measures. The disease onset was a couple of weeks to 2 years after surgery, never within the first 2 weeks after surgery. We did not observe ulceration or breast cancer. Treatment was unnecessary in two patients, whereas hot compresses and nonsteroidal medical drugs were prescribed in one patient. All lesions healed within 2-3 weeks.

Conclusion: Mondor's disease is a possible complication after aesthetic breast surgery but often runs a self-limiting course with spontaneous remission. It is important to exclude breast cancer. The patient should be informed that the disease runs a benign and self-limiting course.

Keywords: Mammoplasty; Mondor’s disease; silicone implant; superficial thrombophlebitis.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
(A) Longitudinal fibrous strings after breast reduction. (B) The same patient with Mondor’s disease of the abdominal wall
Figure 2
Figure 2
(A) Mondor’s thrombophlebitis 2 years after augmentation mammoplasty. (B) The same patient 2 weeks after clinical treatment
Figure 3
Figure 3
Mondor’s disease presenting as a fibrous cord below the right breast 3 weeks after silicone breast implant

References

    1. Mondor H. Tronculite sous-cutanee subaigue de la panoi thoracique antero-laterale. Mem Acad Chir. 1939;65:1271–8.
    1. Alvarez-Garrido H, Garrido-Ríos AA, Sanz-Muñoz C, Miranda-Romero A. Mondor’s disease. Clin Exp Dermatol. 2009;34:753–6. - PubMed
    1. Laroche JP, Galanaud J, Labau D, Van Kien AK, Brisot D, Boge G, et al. Mondor’s disease: what’s new since 1939? Thromb Res. 2012;130:S56–8. - PubMed
    1. Shirah BH, Shirah HA, Alonazie WS. The effectiveness of diclofenac sodium in the treatment of Mondor’s disease of the breast: the topical patch compared to the oral capsules. Breast J. 2017;23:395–400. - PubMed
    1. Shah NA, Gryskiewicz J, Crutchfield CE., 3rd Successful treatment of a recalcitrant Mondor’s cord following breast augmentation. J Clin Aesthet Dermatol. 2014;7:50–1. - PMC - PubMed